参考文献/References:
［1］LEVY G, DEHAENE A, LAURENT N, et al. An update on adenomyosis ［J］. Diagnostic and Interventional Imaging, 2013, 94(1): 3-25.
［2］KORZEKWA A, TUPICKA M, SOCHA B, et al. Is adenomyosis a problem in reproduction and fertility? ［J］. Polish Journal of Veterinary Sciences, 2014, 17(1): 187-194.
［3］DE ZIEGLER D, BORGHESE B, CHAPRON C. Endometriosis and infertility: pathophysiology and management ［J］. Lancet, 2010, 376(9742): 730-738.
［4］CAMPO S, CAMPO V, BENAGIANO G. Adenomyosis and infertility ［J］. Reproductive BioMedicine Online, 2012, 24(1): 35-46.
［5］BARRIER B F, MALINOWSKI M J, DICK E J, et al. Adenomyosis in the baboon is associated with primary infertility ［J］. Fertility and Sterility, 2004, 82(Suppl 3): 1091-1094.
［6］夏丽群，冯云，刘建兵，等GnRHa对改善他莫西芬诱发子宫腺肌病小鼠模型内膜容受性的作用 ［J］生殖与避孕，2011，31（3）：145-151
［7］VERCELLINI P, CONSONNI D, DRIDI D, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis ［J］. Human Reproduction (Oxford, England), 2014, 29(5): 964-977.
［8］TREMELLEN K, RUSSELL P. Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment ［J］. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 2011, 51(3): 280-283.
［9］MARTINEZ-CONEJERO J A, MORGAN M, MONTESINOS M, et al. Adenomyosis does not affect implantation,but is associated with miscarriage in patients undergoing oocyte donation ［J］. Fertility and Sterility, 2011, 96(4): 943-950.
［10］SALIM R, RIRIS S, SAAB W, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF ［J］. Reproductive BioMedicine Online, 2012, 25(3): 273-277.
［11］TOMASSETTI C, MEULEMAN C, TIMMERMAN D, et al. Adenomyosis and subfertility: evidence of association and causation ［J］. Seminars in Reproductive Medicine, 2013, 31(2): 101-108.
［12］DEVLIEGER R, D'HOOGHE T, TIMMERMAN D. Uterine adenomyosis in the infertility clinic ［J］. Human Reproduction Update, 2003, 9(2): 139-147.
［13］MATALLIOTAKIS I M, KATSIKIS I K, PANIDIS D K. Adenomyosis: what is the impact on fertility? ［J］. Current Opinion in Obstetrics & Gynecology, 2005, 17(3): 261-264.
［14］AL JAMA F E. Management of adenomyosis in subfertile women and pregnancy outcome ［J］. Oman Medical Journal, 2011, 26(3): 178-181.
［15］盛燕霞，马彩虹，杨蕊，等不同控制促排卵方案对子宫腺肌病患者体外受精-胚胎移植结局的影响 ［J］生殖与避孕，2010，30（6）：375-378
［16］MAHESHWARI A, GURUNATH S, FATIMA F A. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes ［J］. Human Reproduction Update, 2012, 18(4): 374-392.
［17］JUANG C M, CHOU P, YEN M S, et al. Adenomyosis and risk of preterm delivery ［J］. BJOG-An International Journal of Obstetrics and Gynaecology, 2007, 114(2): 165-169.
［18］KIDO A, KOYAMA T, KATAOKA M, et al. Physiological changes of the human uterine myometrium during menstrual cycle: preliminary evaluation using BOLD Mr imaging ［J］. Journal of Magnetic Resonance Imaging: JMRI, 2007, 26(3): 695-700.
［19］BROSENS I, DERWIG I, BROSENS J, et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? ［J］. Human Reproduction (Oxford, England), 2010, 25(3): 569-574.
［20］张颖，段华子宫内膜-肌层交界区的生理功能与相关疾病 ［J］中华妇产科杂志，2009，44（11）：876-878
［21］汪沙，段华，周莉，等子宫内膜-肌层交界区超微结构的改变与子宫腺肌病发病的关系［J］中华医学杂志，2014，94（27）：2115-2118
［22］YEN C F, HUANG S J, LEE C L, et al. Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment ［J］. Reproductive Sciences (Thousand Oaks, Calif.), 2017, 24(10): 1346-1361.
［23］VANNUCCINI S, TOSTI C, CARMONA F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms［J］. Reproductive BioMedicine Online, 2017, 35(5): 592-601.
［24］CASALS G, ORDI J, CREUS M, et al. Osteopontin and alphavbeta3 integrin expression in the endometrium of infertile and fertile women ［J］. Reproductive BioMedicine Online, 2008, 16(6): 808-816.
［25］XIAO Yu, LI T, XIA Enlan, et al. Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window ［J］. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013, 170(2): 419-422.
［26］XIAO Yu, SUN Xiao, YANG Xiuli, et al. Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window ［J］. Fertility and Sterility, 2010, 94(1): 85-89.
［27］BROWNE H, TAYLOR H. HOXA 10 expression in ectopic endometrial tissue ［J］. Fertility and Sterility, 2006, 85(5): 1386-1390.
［28］FISCHER C P, KAYISILI U, TAYLOR H S. HOXA 10 expression is decreased in endometrium of women with adenomyosis ［J］. Fertility and Sterility, 2011, 95(3): 1133-1136.
［29］MEHASSEB M K, PANCHAL R, TAYLOR A H, et al. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis ［J］. Fertility and Sterility, 2011, 95(7): 2228-2235.e1.
［30］TREMELLEN K P, RUSSELL P. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages ［J］. Journal of Reproductive Immunology, 2012, 93(1): 58-63.
［31］JIANG Yue, JIANG Ruiwei, CHENG Xi, et al. Decreased expression of NR4A nuclear receptors in adenomyosis impairs endometrial decidualization ［J］. Molecular Human Reproduction, 2016, 22(9): 655-668.
相似文献/References:
[1]位玲霞.经阴道超声评价不孕症患者子宫内膜容受性的临床应用价值[J].中国计划生育和妇产科,2011,(01):0.
WEI Ling-xia Staff Room of Gynaecology and Obstetrics,Clinical College of Jining Medical College in Jining city,Shandong Province,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(9):0.
[2]林永红,吴小兰,李兰,等.腹腔镜输卵管吻合术5例报道及文献复习[J].中国计划生育和妇产科,2012,(01):0.
LIN Yong-hong*,WU Xiao-lan,LI Lan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[3]徐永红,史六梅.监测排卵350例临床分析[J].中国计划生育和妇产科,2012,(06):0.
XU Yong-hong,SHI Liu-mei.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[4]查晓霞,游岚岚,周江英,等.输卵管梗阻的超声造影诊断和临床应用分析[J].中国计划生育和妇产科,2013,(02):0.
ZHA Xiao-xia,YOU Lan-lan,ZHOU Jiang-ying,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(9):0.
[5]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[6]苏慧明,徐燕,黎颖雄,等.诺舒子宫内膜去除术治疗子宫腺肌病致月经过多的临床研究[J].中国计划生育和妇产科,2014,(03):0.
SU Hui-ming,XU Yan,LI Ying-xiong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[7]毛世华,谭晓燕,范玲,等.高强度聚焦超声联合米非司酮治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
MAO Shi-hua,TAN Xiao-yan,FAN Ling,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[8]王亚丛,王丽,喻琳麟,等.轻度子宫内膜异位症合并不孕症患者术后促排卵对妊娠的影响[J].中国计划生育和妇产科,2014,(05):0.
WANG Ya-cong,WANG Li,YU Lin-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[9]邓淑珍.曼月乐宫内节育器治疗子宫腺肌病的疗效观察[J].中国计划生育和妇产科,2014,(05):0.
DENG Shu-zhen,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[10]王宇慧,魏绍斌.中成药治疗子宫内膜异位症和子宫腺肌病的辨证应用[J].中国计划生育和妇产科,2015,(02):0.
[11]常梦茹,卢美松*,张丹丹.磁共振引导高强度聚焦超声术治疗子宫腺肌病的临床研究进展[J].中国计划生育和妇产科,2018,(9):6.
[12]徐冰.子宫腺肌病合并不孕的管理现状及展望[J].中国计划生育和妇产科,2019,(4):10.